COVID-19: Kerala likely to increase liquor outlets to prevent crowding

Kerala Government may radically expand the number of liquor outlets in the state by tomorrow to prevent crowding at the existing outlets. Kerala State Beverages Corporation, along with Kerala State Co-operatives Consumers’ Federation, has a legal monopoly over the retailing of liquor in Kerala. However, with only around 300 outlets to serve a population of […]

CORONAVIRUS: Superstar Mohanlal calls for magical clapping

Malayalam Superstar Mohanlal expressed frustration at the high number of people who are refusing to heed government’s instructions on combating Coronavirus, and compared community clapping to magic that can destroy bacteria and viruses. “It won’t do to just say that we are not used to [such restrictions],” Mohanlal said in an interview with Malayalam channel […]

AYUSH Ministry hits back over criticism of Coronavirus advisory

The ministry of traditional medicines at Government of India has hit back at critics who have questioned the medical validity of its recent advisory on countering Coronavirus through herbal medicine. The AYUSH ministry had issued a list of dos and don’ts last week, including items such as ensuring proper personal hygiene, wearing face masks in […]

Biocon gets Form 483 observations for API plant

The US Food and Drug Administration has issued a Form 483 with five observations for Biocon’s API Manufacturing facility. Form 483 observations are issued when US FDA inspectors notice shortcomings in a company’s manufacturing processes, data storage and so on during an inspection. The company has to address the issues raised in the Form 483 […]

Alembic gets two observations for Karkhadi plant

Alembic Pharmaceuticals, one of India’s biggest drug makers, received two observations from US FDA officials who inspected its plant at Karkhadi in Gujarat. Observations, given in Form 483, indicate that the inspectors were not fully satisfied with what they found during the visit. In a Form 483, the FDA typically outlines conditions or practices at […]

Natco Pharma seeks nod for generic copy of Taiho’s cancer drug Lonsurf

India-based Natco Pharma has filed an application with the US Food and Drug Administration seeking permission to market a generic copy of Lonsurf, a drug approved just four years ago to treat colorectal/gastric cancers. The application has been filed with a ‘Paragraph IV’ declaration. Such a declaration essentially states that the filer, Natco, believes that […]

Sun Pharma launches dry-eye treatment in the US

Sun Pharmaceutical Industries Ltd said one of its wholly-owned subsidiaries has commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. CEQUA, which offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration (FDA), is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye), an inflammatory […]

Morepen Labs readies multi-billion APIs for manufacturing from Dec

Pharmaceuticals manufacturer Morepen Laboratories Ltd said it is ready to start manufacturing and selling three multi-billion dollar drugs, two of which are set to go off-patent in December this year. The current global market size for Rivaroxaban, a powerful anticoagulant (blood thinner), is $7.19 billion (Rs. 51,000 cores). It is the 10th largest selling drug […]

Lupin appoints Apotex veteran as new head of quality

Pharmaceuticals maker Lupin has appointed a new head of quality for the company, as it strives to remain compliant with international safety and manufacturing norms throughout its vast manufacturing base across the world. Johnny Mikell, the new global head of quality, comes from a similar role at Canada-based pharmaceutical manufacturer Apotex, and has 35 years […]

Thyrocare board says no to founder Velumani’s offer to buy scanning arm

Directors of diagnostic chain Thyrocare today said no to founder and chairman Arokiaswamy Velumani’s offer to buy out its latest venture aimed at democratising access to cancer diagnostic services. At present, cancer screening and diagnostic services are extremely expensive, and Velumani — the son of a landless farmer — has been working for some time […]

Lupin sells Japanese injectables business to UAE-based Neopharma

Pharma major Lupin said it has agreed to sell its Japanese injectables business to a wholly owned subsidiary of Neopharma group, the UAE’s largest pharmaceutical manufacturer headquartered in Abu Dhabi. Lupin has agreed to sell all the issued and outstanding share capital in its unit Kyowa Criticare Co. Ltd to neo ALA Co. Ltd, a […]

Cadila Healthcare Moraiya plant could face FDA action

Cadila Healthcare today said that the US FDA has classified its Moraiya factory near Ahmedabad as ‘official action indicated’ or OAI. OAI is one of the three types of classification that a plant inspection report is put under after an FDA inspection. The three classifications are ‘no action indicated’, ‘voluntary action indicated’ and ‘official action […]

Lupin’s Aurangabad plant passes USFDA inspection

Pharma manufacturer Lupin said its Aurangabad factory has successfully obtained an Establishment Inspection Report (EIR) from the US FDA for its May inspection. The receipt of an EIR signifies the successful closing of the inspection as far as the company is concerned. Lupin’s Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral […]

Caplin Point Labs Chennai plant passes USFDA checks

Caplin Point Laboratories said it has received an Establishment Inspection Report (EIR) from the US FDA for a recently concluded inspection at the manufacturing plan run by its unit Caplin Steriles Limited. “This was the third successful US FDA audit at the plant since 2016,” the company said, referring to the June inspection. An EIR […]

MP, Maharashtra worst at managing H1N1 in India

Maharashtra, Madhya Pradesh and Chhattisgarh have the dubious distinction of being the worst states for H1N1 patients in India. Not only do they have relatively high number of patients, but your chances of making it alive as an H1N1 patient are also the lowest in India in these states. Other states — Gujarat, Rajasthan and […]